Drug Type T-lymphocyte cell therapy |
Synonyms Autologous d T Lymphocytes, Autologous g T Lymphocytes, Autologous T Lymphocytes + [1] |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Neoplasms | Phase 3 | GB | - | |
Melanoma | Phase 3 | GB | - | |
Non-Small Cell Lung Cancer | Phase 3 | GB | - |
Not Applicable | - | (LMP2 CTLs) | zuovjonnai(iaseizjrso) = wguzokiwig vgtqzvqpzn (eauqtgidbr ) View more | - | 01 Feb 2009 | ||
(LMP1/2 CTLs) | ktlaulxdqz(mrzebwkvaq) = qmhfzuzytu mkrzipxqli (qubhfngosy ) |